Skip to content

KANGFUXIN solution for the prevention of radiation-induced skin injury in breast cancer patients: A pilot study.

KANGFUXIN solution for the prevention of radiation-induced skin injury in breast cancer patients: A pilot study.

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075483
Enrollment
Unknown
Registered
2023-09-06
Start date
2022-10-08
Completion date
Unknown
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radiation-induced skin injury

Interventions

Sponsors

The First Affiliated Hospital of Guangdong Pharmaceutical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Female, 18 years old =75 years old; 2. Breast-conserving or total resection of breast cancer has been completed; 3. Patients receiving Postoperative adjuvant radiotherapy for breast cancer in our hospital; 4. The radiotherapy plan of chest wall ± axilla was made by the oncologist.

Exclusion criteria

Exclusion criteria: 1. Previous history of radiotherapy to the ipsilateral breast or chest wall; 2. History of connective tissue disease; 3. Skin rash, ulcers, or bleeding on the breast or chest wall; 4. There were still unhealed surgical wounds in the radiotherapy field before the start of radiotherapy; 5. Severe heart or cardiovascular disease or condition, severe renal insufficiency; 6. Other concurrent serious medical conditions that may interfere with planned treatment, including severe pulmonary disease; 7. Pregnant or lactating women; 8. Allergy to any ingredient or excipient of the study drug.

Design outcomes

Primary

MeasureTime frame
Degree of radiation-induced skin injury;

Secondary

MeasureTime frame
Skindex-16 Scale score;

Countries

China

Contacts

Public ContactLIN Yufeng

The First Affiliated Hospital of Guangdong Pharmaceutical University

ricy2010@yeah.net18818914509

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026